BCMA-GPRC5D CAR-T

· Guangzhou Bio-gene Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BCMA-GPRC5D CAR-T, covering 2025-09-26 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment [NA]

See pricing